ALPHA TRIBE

Natco Pharma LimitedBoard Meeting, 14-08-2026: Outcome of Board Meeting

14-08-2026 | 02:12 pm

NATCO Pharma board approved Q1FY27 consolidated results: revenue ₹794.4 Cr, net profit ₹206.5 Cr. Declared ₹1.50/share interim dividend. Also exploring fundraising up to ₹2000 Cr. #NATCOPHARM

No comments yet. Be the first to comment!

All announcements from Natco Pharma Limited